Five Prime Therapeutics, two new leaders
This article was originally published in Scrip
Innovative biologics company Five Prime Therapeutics has appointed Dr Lewis Williams president and CEO and Brian Atwood chair of the board. Dr Williams, the founder of Five Prime, was previously CSO and a director of Chiron Corporation and president of Chiron Technologies. Mr Atwood co-founded Versant Ventures, a healthcare focused venture capital firm where he serves as managing director.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.